#Harvoni

A brief look at current data on hepatitis C treatment response rates in Blacks using the newest direct-acting antivirals.

A recent study of Dutch clinicians found that they generally did a good job of preventing drug-drug interactions.

Ending the epidemic is going to require addressing the fact that certain individuals are at high risk of reinfection after a cure.

National guidelines have indicated that Blacks who qualify for the eight-week hep C treatment should nevertheless take 12 weeks.

Among a large group treated with minimal or no liver fibrosis, liver-health problems were almost nonexistent up to three years later.

The drugmaker is accused of infringing on a patent held by rival Merck & Co. over its formulas for Sovaldi and Harvoni treatment.

These include a low CD4 count, having cirrhosis and taking certain hep C drug regimens.

Fighting Hep C, using the fury to stoke the fire within.

The U.S. FDA released November 13, 2017 new updates on Hepatitis C treatment medications.

In a recent small study of HIV-positive men who had recently contracted hepatitis C, Harvoni had a perfect cure rate.

A roundup of key findings from the Annual Meeting of the American Association for the Study of Liver Diseases in Washington, DC

Among a large group treated with minimal or no liver fibrosis, liver-health problems were almost nonexistent up to three years later.

The hepatitis C regimen was tested in a small group with severe kidney impairment.

One research team has broken down the risk and benefits associated with treating more people in eight weeks or fewer.